By Ms Sheetal Ladva, Chief Pharmaceutical Officer’s Clinical Fellow for RPS and Macmillan Cancer Support

Unlocking the power of neighbourhood pharmacy in earlier cancer detection

The National Cancer Plan sets a clear ambition: diagnose cancer earlier, improve outcomes and deliver personalised care. To achieve this, we must look closely at where people naturally seek support. For many, their most regular contact with the NHS is their local pharmacy.

Community and primary care pharmacists and pharmacy technicians build trusted relationships, notice subtle changes and hold everyday conversations that often reveal the first signs of concern. These interactions—familiar, informal and rooted in the neighbourhood—create powerful opportunities to encourage screening, discuss symptoms and support safer medicines use. When pharmacy is fully integrated into early detection pathways, timely identification, reassurance and joined‑up care become possible in every community.

Prevention, screening support and early conversations

Pharmacy teams already play a central role in prevention—supporting smoking cessation, weight management, UV‑safety advice, alcohol reduction and HPV vaccination. These simple, everyday interactions create natural openings to talk about cancer risks and screening uptake.

Because pharmacists and pharmacy technicians see people who may not always respond to bowel, breast, cervical or lung screening invitations, they are uniquely placed to promote uptake. A brief conversation can lead to life-saving action.

Identifying warning signs through real‑life interactions

Pharmacy teams see people regularly and often notice subtle changes others may miss. Repeated purchases of indigestion remedies, cough mixtures or pain relief can signal concerns worth exploring sensitively.

Training resources such as the RPS guidance Utilising Community Pharmacists to Support People with Cancer helps teams recognise early red‑flag symptoms and hold sensitive safety netting conversations. Community pilots, such as heartburn checks, show how simple interactions can lead to timely escalation and earlier diagnosis.

Polypharmacy, cancer and MDT working

I’m working with the RPS and Macmillan Cancer Support to highlight a significant clinical gap: many people living with cancer also take multiple medicines for other long‑term conditions. This can mask early symptoms, increase treatment burden and complicate toxicity.

Using tools like the RPS Repeat Prescribing Toolkit, pharmacy teams can reduce avoidable harm, simplify regimens and surface unexplained symptom patterns that may require further investigation.

This work is strongest when embedded in multidisciplinary teams (MDT), where pharmacists and pharmacy technicians contribute to discussions on symptom changes, supportive care needs, frailty and escalation. Close collaboration with GPs, oncologists, nurses and diagnostics teams ensures people receive safer, more coordinated care.

Tackling inequalities through neighbourhood insight

Pharmacies understand the communities they serve – the cultural barriers, language needs, digital exclusion and practical challenges such as work or childcare. This insight is invaluable for targeted outreach, supporting earlier detection in groups who often present late. By addressing inequalities at a neighbourhood level, pharmacy strengthens national efforts to diagnose cancer sooner.

Compassionate end‑of‑life care in the community

Pharmacy’s impact extends beyond early detection. Pharmacy teams play a crucial role in supporting people at the end of life, ensuring comfort, dignity and timely access to essential palliative medicines. Many community pharmacies follow the Daffodil Standards, demonstrating their commitment to personalised, compassionate care. Their neighbourhood presence helps prevent unnecessary hospital admissions and ensures people receive comfort and dignity at home.

What needs to happen next

Pharmacy’s unique combination of clinical skill, accessibility and trusted relationships positions the profession to lead the neighbourhood response to earlier cancer detection. To unlock this potential, early detection must be commissioned and integrated into everyday pharmacy practice.

This includes:

• Symptom‑based referral pathways
• Consistent MDT‑embedded pharmacy roles
• Expansion of prevention and screening‑support services
• Full digital access to patient records

By drawing on training resources, signposting people to trusted information and working closely with organisations such as Cancer Research UK, Macmillan Cancer Support and Marie Curie, pharmacy teams can detect cancer earlier, reduce inequalities and deliver safer, more personalised care.

The opportunity to strengthen our neighbourhood contribution is here. Pharmacy is ready to lead - now the system must enable it.

Read more RPS blogs.